DONG A SOCIO HOLDINGS CO LTD has a total of 27 patent applications. It increased the IP activity by 33.0%. Its first patent ever was published in 2006. It filed its patents most often in Republic of Korea, EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are YUHAN CORP, CEN JUNDA and AB PHARMA LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Republic of Korea | 6 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | United States | 3 | |
#4 | Australia | 2 | |
#5 | China | 2 | |
#6 | Mexico | 2 | |
#7 | WIPO (World Intellectual Property Organization) | 2 | |
#8 | Canada | 1 | |
#9 | Chile | 1 | |
#10 | Costa Rica | 1 | |
#11 | Israel | 1 | |
#12 | Peru | 1 | |
#13 | Philippines | 1 | |
#14 | Russian Federation | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Heterocyclic compounds | |
#4 | Peptides | |
#5 | Microorganisms | |
#6 | Fermentation | |
#7 | Enzymes | |
#8 | Microbiology |
# | Name | Total Patents |
---|---|---|
#1 | Park Seong Jin | 15 |
#2 | Kim Hadong | 15 |
#3 | Yoon Taeyoung | 15 |
#4 | Jang Mi Yeon | 15 |
#5 | Kim Jin Kwan | 15 |
#6 | Ryu Ki Moon | 15 |
#7 | Park Taesun | 13 |
#8 | Sheen Joon-Ho | 12 |
#9 | Kim Sumin | 12 |
#10 | Kim Myeong-Seop | 11 |
Publication | Filing date | Title |
---|---|---|
US2019315716A1 | Heteroaryl compounds and their use as Mer inhibitors | |
PE20181017A1 | HETEROARYL COMPOUNDS AND THEIR USE AS THERAPEUTIC DRUGS | |
KR20140141818A | Anti-vegf antibodies and pharmaceutical composition comprising same for preventing, diagnosing or treating cancer or angiogenesis-related disease | |
KR20140096534A | Highly efficient production methods of fusion proteins for antibody treatment using catechin | |
KR20140002842A | Cell culture device of perfusion type | |
KR20130067406A | Method of preparing a therapeutic human recombinant glucocerebrosidase | |
KR20130055411A | Method of preparing a therapeutic antibody fusion protein |